Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma
- PMID: 6712322
- PMCID: PMC1353366
- DOI: 10.1097/00000658-198404000-00014
Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma
Abstract
Plasma calcitonin (CT) levels were measured serially in 54 patients surgically treated for medullary thyroid carcinoma. Patients with postoperative basal CT levels higher than 1 ng/ml measured within 1 month after surgery had a higher recurrence rate than those with lower CT levels (p less than 0.002). Patients with postoperative basal CT levels higher than 2 ng/ml had a lower survival rate than those with lower CT levels (p less than 0.01). However, preoperative basal CT levels had no significant correlation with life expectancy or recurrence during the present observation period. Serial measurements in 23 patients with elevated postoperative CT levels showed exponential increases in basal CT levels in 19 patients (p less than 0.05 in nine patients, 0.05 less than p less than 0.1 in four patients) and slight decreases in four (p less than 0.05 in one patient). Doubling time of CT levels calculated from the regression line in each patient showed the highest correlation with 3-year survival, recurrence within 5 years, and time interval between surgery and clinical recurrence of the tumor, allowing quantitative prediction of the prognosis.
Similar articles
-
[Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].Gan No Rinsho. 1986 Oct;32(12):1519-24. Gan No Rinsho. 1986. PMID: 3783976 Japanese.
-
[Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels].Nihon Geka Gakkai Zasshi. 1987 Jan;88(1):102-8. Nihon Geka Gakkai Zasshi. 1987. PMID: 3821708 Japanese.
-
Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?Asian Pac J Cancer Prev. 2016;17(7):3357-62. Asian Pac J Cancer Prev. 2016. PMID: 27509975
-
Long-Term Follow-up in Medullary Thyroid Carcinoma.Recent Results Cancer Res. 2015;204:207-25. doi: 10.1007/978-3-319-22542-5_10. Recent Results Cancer Res. 2015. PMID: 26494391 Review.
-
Surgical treatment of medullary carcinoma of the thyroid.Otolaryngol Clin North Am. 1990 Jun;23(3):453-73. Otolaryngol Clin North Am. 1990. PMID: 1973281 Review.
Cited by
-
Spontaneous Deceleration and Acceleration of Growth Rate in Medullary Thyroid Carcinomas Suggested by Changes in Calcitonin Doubling Times Over Long-Term Surveillance.World J Surg. 2019 Feb;43(2):504-512. doi: 10.1007/s00268-018-4789-1. World J Surg. 2019. PMID: 30229381 Free PMC article.
-
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.Eur Radiol. 2009 Jun;19(6):1425-34. doi: 10.1007/s00330-008-1280-7. Epub 2009 Jan 21. Eur Radiol. 2009. PMID: 19156423
-
Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.Cancer. 2017 Aug 1;123(15):2955-2964. doi: 10.1002/cncr.30690. Epub 2017 Apr 3. Cancer. 2017. PMID: 28369717 Free PMC article.
-
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. Thyroid. 2015. PMID: 25810047 Free PMC article. Review.
-
Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.Endocr Pathol. 2003 Summer;14(2):123-31. doi: 10.1385/ep:14:2:123. Endocr Pathol. 2003. PMID: 12858002 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical